SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Extended search

L773:0959 4973
 

Search: L773:0959 4973 > Uppsala University > Blom Kristin > Assessment in vitro...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Assessment in vitro of interactions between anti-cancer drugs and noncancer drugs commonly used by cancer patients

Andersson, Claes (author)
Uppsala universitet,Cancerfarmakologi och beräkningsmedicin
Ye, Jiawei (author)
Uppsala universitet,Institutionen för medicinska vetenskaper,Southeast Univ, Sch Med, Dept Med Lab Sci, Nanjing, Peoples R China.
Blom, Kristin (author)
Uppsala universitet,Cancerfarmakologi och beräkningsmedicin
show more...
Fryknäs, Mårten (author)
Uppsala universitet,Cancerfarmakologi och beräkningsmedicin
Larsson, Rolf (author)
Uppsala universitet,Cancerfarmakologi och beräkningsmedicin
Nygren, Peter (author)
Uppsala universitet,Cancerprecisionsmedicin
show less...
 (creator_code:org_t)
Lippincott Williams & Wilkins, 2023
2023
English.
In: Anti-Cancer Drugs. - : Lippincott Williams & Wilkins. - 0959-4973 .- 1473-5741. ; 34:1, s. 92-102
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Cancer patients often suffer from cancer symptoms, treatment complications and concomitant diseases and are, therefore, often treated with several drugs in addition to anticancer drugs. Whether such drugs, here denoted as 'concomitant drugs', have anticancer effects or interact at the tumor cell level with the anticancer drugs is not very well known. The cytotoxic effects of nine concomitant drugs and their interactions with five anti-cancer drugs commonly used for the treatment of colorectal cancer were screened over broad ranges of drug concentrations in vitro in the human colon cancer cell line HCT116wt. Seven additional tyrosine kinase inhibitors were included to further evaluate key findings as were primary cultures of tumor cells from patients with colorectal cancer. Cytotoxic effects were evaluated using the fluorometric microculture cytotoxicity assay (FMCA) and interaction analysis was based on Bliss independent interaction analysis. Simvastatin and loperamide, included here as an opioid agonists, were found to have cytotoxic effects on their own at reasonably low concentrations whereas betamethasone, enalapril, ibuprofen, metformin, metoclopramide, metoprolol and paracetamol were inactive also at very high concentrations. Drug interactions ranged from antagonistic to synergistic over the concentrations tested with a more homogenous pattern of synergy between simvastatin and protein kinase inhibitors in HCT116wt cells. Commonly used concomitant drugs are mostly neither expected to have anticancer effects nor to interact significantly with anticancer drugs frequently used for the treatment of colorectal cancer.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Keyword

anti-cancer drug
concomitant medication
combinations
drug interactions

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Find more in SwePub

By the author/editor
Andersson, Claes
Ye, Jiawei
Blom, Kristin
Fryknäs, Mårten
Larsson, Rolf
Nygren, Peter
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Clinical Medicin ...
and Cancer and Oncol ...
Articles in the publication
Anti-Cancer Drug ...
By the university
Uppsala University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view